These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2016218

  • 1. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL, McCracken JT, Cantwell DP.
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [Abstract] [Full Text] [Related]

  • 2. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 3. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

  • 4. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 5. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [Abstract] [Full Text] [Related]

  • 6. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
    DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P.
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):45-9. PubMed ID: 1537780
    [Abstract] [Full Text] [Related]

  • 7. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR, Jones B, Olson S, Perel JM.
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [Abstract] [Full Text] [Related]

  • 8. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH, Meador M, Fortune T, Llorena R.
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [Abstract] [Full Text] [Related]

  • 9. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Agras WS.
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [Abstract] [Full Text] [Related]

  • 10. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 11. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P.
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [Abstract] [Full Text] [Related]

  • 12. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M, Jones B, Olson S, Perel JM.
    Psychopharmacol Bull; 1990 Apr; 26(1):119-22. PubMed ID: 2371366
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 14. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R, McLeod DR, Zimmerli WD, Hipsley PA.
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [Abstract] [Full Text] [Related]

  • 15. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 16. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
    Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():36-43; discussion 55-8. PubMed ID: 2199433
    [Abstract] [Full Text] [Related]

  • 17. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():35-8. PubMed ID: 1517555
    [No Abstract] [Full Text] [Related]

  • 18. Clomipramine for obsessive-compulsive disorder.
    Feinberg M.
    Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
    [Abstract] [Full Text] [Related]

  • 19. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS, Marks IM, Wright J, Luscombe DK.
    Postgrad Med J; 1980 May; 56 Suppl 1():134-9. PubMed ID: 7393824
    [Abstract] [Full Text] [Related]

  • 20. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG, Thatte S, Wiggins D.
    Psychopharmacol Bull; 1990 May; 26(3):285-90. PubMed ID: 2274627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.